Chip Stewart

Chip Stewart

Auto-generated profile, based on publicly available information

Chip Stewart

Cancer Program Broad Institute of MIT and Harvard 02142 Cambridge MA USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
DBDavid Benjamin
David Benjamin
TSTakutop Sato
Takutop Sato
KCKristian Cibulskis
Kristian Cibulskis
GGGad Getz
Gad Getz
CSChip Stewart
Chip Stewart
LLLee Lichtenstein
Lee Lichtenstein
Mutect2 is a somatic variant caller that uses local assembly and realignment to detect SNVs and indels. Assembly implies whole haplotypes and read pairs, rather than single bases, as the atomic units of biological variation and sequencing evidence, improving variant calling. Beyond local assembly and alignment, Mutect2 is based on several probabilistic models for genotyping and filtering that work well with and without a matched normal sample and for all sequencing depths.

1 December 2018 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
JHJulija Hmeljak
Julija Hmeljak
FSFrancisco Sanchez-Vega
Francisco Sanchez-Vega
KHKatherine A Hoadley
Katherine A Hoadley
JSJuliann Shih
Juliann Shih
CSChip Stewart
Chip Stewart
MLMarc Ladanyi
Marc Ladanyi
Malignant pleural mesothelioma (MPM) is a highly lethal cancer of the lining of the chest cavity. To expand our understanding of MPM, we conducted a comprehensive integrated genomic study, including the most detailed analysis of BAP1 alterations to date. We identified histology-independent molecular prognostic subsets, and defined a novel genomic subtype with TP53 and SETDB1 mutations and extensive loss of heterozygosity. We also report strong expression of the immune-checkpoint gene VISTA in epithelioid MPM, strikingly higher than in other solid cancers, with implications for the immune response to MPM and for its immunotherapy. Our findings highlight new avenues for further investigation of MPM biology and novel therapeutic options. Significance: Through a comprehensive integrated genomic study of 74 MPMs, we provide a deeper understanding of histology-independent determinants of aggressive behavior, define a novel genomic subtype with TP53 and SETDB1 mutations and extensive loss of heterozygosity, and discovered strong expression of the immune-checkpoint gene VISTA in epithelioid MPM. See related commentary by Aggarwal and Albelda, p. 1508. This article is highlighted in the In This Issue feature, p. 1494

7 June 2019 in Science
Verified
Journal Article
Closed access
PDF file
KYKeren Yizhak
Keren Yizhak
FAFrançois Aguet
François Aguet
JKJaegil Kim
Jaegil Kim
JHJulian M. Hess
Julian M. Hess
KKKirsten Kübler
Kirsten Kübler
GGGad Getz
Gad Getz
Somatic mosaicism in normal tissues: Somatic cells can accumulate mutations over the course of an individual's lifetime. This generates cells that differ genetically at specific loci within the genome. To explore how this genetic diversity in individuals contributes to disease, Yizhak et al. developed a method to detect mutations from RNA sequencing data (see the Perspective by Tomasetti). Applying this method to Cancer Genome Atlas samples and normal samples from the Genotype-Tissue Expression (GTEx) project generated a tissue-specific study of mutation accumulation. Somatic mutations were detected in nearly all individuals and across many normal human tissues in genomic regions called cancer hotspots and in genes that play a role in cancer. Interestingly, the skin, lung, and esophagus exhibited the most mutations, suggesting that the environment generates many human mutations. Science , this issue p. eaaw0726 ; see also p. 938

13 March 2018 in Genome Research
Verified
Journal Article
Open access
PDF file
JWJeremiah A. Wala
Jeremiah A. Wala
PBPratiti Bandopadhayay
Pratiti Bandopadhayay
NGNoah F. Greenwald
Noah F. Greenwald
RORyan O'Rourke
Ryan O'Rourke
TSTed Sharpe
Ted Sharpe
RBRameen Beroukhim
Rameen Beroukhim
Structural variants (SVs), including small insertion and deletion variants (indels), are challenging to detect through standard alignment-based variant calling methods. Sequence assembly offers a powerful approach to identifying SVs, but is difficult to apply at scale genome-wide for SV detection due to its computational complexity and the difficulty of extracting SVs from assembly contigs. We describe SvABA, an efficient and accurate method for detecting SVs from short-read sequencing data using genome-wide local assembly with low memory and computing requirements. We evaluated SvABA's performance on the NA12878 human genome and in simulated and real cancer genomes. SvABA demonstrates superior sensitivity and specificity across a large spectrum of SVs and substantially improves detection performance for variants in the 20–300 bp range, compared with existing methods. SvABA also identifies complex somatic rearrangements with chains of short (<1000 bp) templated-sequence insertions copied from distant genomic regions. We applied SvABA to 344 cancer genomes from 11 cancer types and found that short templated-sequence insertions occur in ∼4% of all somatic rearrangements. Finally, we demonstrate that SvABA can identify sites of viral integration and cancer driver alterations containing medium-sized (50–300 bp) SVs.

22 April 2021 in Science
Verified
Journal Article
Closed access
PDF file
LMLindsay M. Morton
Lindsay M. Morton
DKDanielle M. Karyadi
Danielle M. Karyadi
CSChip Stewart
Chip Stewart
TBTetiana Bogdanova
Tetiana Bogdanova
EDEric T. Dawson
Eric T. Dawson
SCStephen J. Chanock
Stephen J. Chanock
Genomics of radiation-induced damage: The potential adverse effects of exposures to radioactivity from nuclear accidents can include acute consequences such as radiation sickness, as well as long-term sequelae such as increased risk of cancer. There have been a few studies examining transgenerational risks of radiation exposure but the results have been inconclusive. Morton et al. analyzed papillary thyroid tumors, normal thyroid tissue, and blood from hundreds of survivors of the Chernobyl nuclear accident and compared them against those of unexposed patients. The findings offer insight into the process of radiation-induced carcinogenesis and characteristic patterns of DNA damage associated with environmental radiation exposure. In a separate study, Yeager et al. analyzed the genomes of 130 children and parents from families in which one or both parents had experienced gonadal radiation exposure related to the Chernobyl accident and the children were conceived between 1987 and 2002. Reassuringly, the authors did not find an increase in new germline mutations in this population. Science , this issue p. eabg2538 , p. 725

9 December 2019 in Blood Advances
Verified
Journal Article
Open access
PDF file
KWKirsty Wienand
Kirsty Wienand
BCBjörn Chapuy
Björn Chapuy
CSChip Stewart
Chip Stewart
ADAndrew J. Dunford
Andrew J. Dunford
DWDavid Wu
David Wu
MSMargaret A. Shipp
Margaret A. Shipp
Key Points: Analyses of recurrent mutations, copy number alterations, and structural variants reveal complementary immune evasion mechanisms in cHL. The mutational burden in EBV– cHLs is among the highest reported, potentially contributing to the efficacy of PD-1 blockade.